Shining the Spotlight on Multiple Daily Insulin Therapy: Real-World Evidence of the InPen Smart Insulin Pen

Forgot your password?

Select specialty

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

By ADA 2024 Insights FEATURING Janice Macleod

August 2, 2024

Ilene Fennoy

Practical Ways to Achieve Targets in Diabetes Care

University of Colorado Department of Medicine

Feat. J. Okemah

Feat. M. Heyman

Feat. F. Pasquel

Diana Isaacs

Keck School of Medicine of USC

Diana Isaacs

Robert Busch

Michigan Medicine - Podiatry

G. Rothenberg

Jennifer Rosselli

S. Twillmann

Krista Varady

Login

Login

Join VuMedi

Shining the Spotlight on Multiple Daily Insulin Therapy: Real-World Evidence of the InPen Smart Insulin Pen

Discover the MOA of an Incretin Medication for T2D

Discover the MOA of an Incretin Medication for T2D

Recommended

Obesity and Diabetes in Children

Is There a Future for HbA1c? (Moving Towards CGM: GMI and TIR)

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

Optimizing Omnipod® 5 for Better Patient Outcomes (featuring Jennife…

Advancing Type 2 Diabetes Care with Omnipod® 5

Labs to Check on Semaglutide or Tirzepatide

Mind over diabetes: a psychologist’s take on the freedom of Omnipod®…

Type 2 Diabetes and Omnipod® 5--Unveiling SECURE T2D

Tirzepatide Updates

Weightloss in Menopause

Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

Tirzepatide for Type 2 Diabetes

The Differences Between the Products of GLP1's and GLP/GIPs

Could It Be Cushing’s? Rethinking Diabetes Management with the CATAL…

Optimizing Omnipod 5 Therapy: Case Studies - TCOYD

Diabetic Peripheral Neuropathy: A Review of Clinical Practice Guidel…

Switch, Change, Rearrange: Diabetes Medication Transitions, De-presc…

Wegovy 2024 Updates

ADA 2022 Flipping the Metabolic Switch: Intermittent Fasting as a We…